Abbott Laboratories (ABT)

US — Healthcare Sector
Peers: ABBV  LLY  BMY  JNJ  MDT 

Automate Your Wheel Strategy on ABT

With Tiblio's Option Bot, you can configure your own wheel strategy including ABT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ABT
  • Rev/Share 24.2351
  • Book/Share 28.0812
  • PB 4.7823
  • Debt/Equity 0.2713
  • CurrentRatio 1.7805
  • ROIC 0.1913

 

  • MktCap 232442624000.0
  • FreeCF/Share 3.8101
  • PFCF 34.917
  • PE 17.2884
  • Debt/Assets 0.1626
  • DivYield 0.0171
  • ROE 0.3076

 

  • Rating A-
  • Score 4
  • Recommendation Buy
  • P/E Score 2
  • DCF Score 4
  • P/B Score 2
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation ABT Leerink Partners -- Market Perform -- $143 June 16, 2025
Initiation ABT Oppenheimer -- Outperform -- $130 Oct. 8, 2024
Initiation ABT Piper Sandler -- Overweight -- $131 Sept. 19, 2024

News

Abbott (ABT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ABT
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Positive

Abbott (ABT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Read More
image for news Abbott (ABT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ABT's FreeStyle Libre 3 Plus Now Available in Canada: Stock to Rise?
ABT
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Neutral

Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor.

Read More
image for news ABT's FreeStyle Libre 3 Plus Now Available in Canada: Stock to Rise?
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
ABT
Published: July 04, 2025 by: Zacks Investment Research
Sentiment: Positive

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Read More
image for news Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
ABT
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Neutral

In the closing of the recent trading day, Abbott (ABT) stood at $134.11, denoting a -1.58% move from the preceding trading day.

Read More
image for news Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
Abbott (ABT) Upgraded to Buy: Here's What You Should Know
ABT
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive

Abbott (ABT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Read More
image for news Abbott (ABT) Upgraded to Buy: Here's What You Should Know
Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion
ABT
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive

ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.

Read More
image for news Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
ABT
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Read More
image for news Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
Abbott Labs: Proactive, Adaptive, Solid
ABT
Published: June 30, 2025 by: Seeking Alpha
Sentiment: Positive

Abbott's proactive leadership and diversified business model help it navigate macro challenges and market volatility effectively. Strong Q1 performance in Nutrition, Medical Devices, and Vascular segments offsets weakness in Diagnostics and China sales, showcasing resilience and adaptability. Management's focus on gross margin expansion, cost-saving initiatives, and shareholder-friendly policies like dividend increases support long-term value.

Read More
image for news Abbott Labs: Proactive, Adaptive, Solid
NVST vs. ABT: Which Stock Is the Better Value Option?
ABT, NVST
Published: June 26, 2025 by: Zacks Investment Research
Sentiment: Neutral

Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?

Read More
image for news NVST vs. ABT: Which Stock Is the Better Value Option?
Should You Continue to Retain Abbott Stock in Your Portfolio Now?
ABT
Published: June 24, 2025 by: Zacks Investment Research
Sentiment: Neutral

ABT rides on strong global demand in diagnostics and diabetes care, but macro headwinds may test its momentum ahead.

Read More
image for news Should You Continue to Retain Abbott Stock in Your Portfolio Now?
New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier
ABT
Published: June 20, 2025 by: PRNewsWire
Sentiment: Neutral

Randomized, controlled clinical trial presented as a late-breaking poster at ADA's Scientific Sessions shows people participating in Abbott's Healthy Food Rx ate more vegetables and fruit, and reported significantly improved health status. Abbott's Healthy Food Rx community-focused "food is medicine" program provides home-delivered healthy food boxes and nutrition education in Stockton, Calif.

Read More
image for news New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
ABT
Published: June 19, 2025 by: Zacks Investment Research
Sentiment: Positive

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read More
image for news Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?
ABT
Published: June 19, 2025 by: Zacks Investment Research
Sentiment: Positive

Abbott gains Health Canada approval for its i-STAT TBI test, enabling rapid bedside concussion detection via whole blood.

Read More
image for news ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?
Abbott Declares 406th Consecutive Quarterly Dividend
ABT
Published: June 13, 2025 by: PRNewsWire
Sentiment: Neutral

ABBOTT PARK, Ill., June 13, 2025 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.

Read More
image for news Abbott Declares 406th Consecutive Quarterly Dividend
NVST vs. ABT: Which Stock Should Value Investors Buy Now?
ABT, NVST
Published: June 10, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in stocks from the Medical - Products sector have probably already heard of Envista (NVST) and Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now?

Read More
image for news NVST vs. ABT: Which Stock Should Value Investors Buy Now?
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
ABT
Published: June 05, 2025 by: Zacks Investment Research
Sentiment: Neutral

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Read More
image for news Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
ABT
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Neutral

Abbott (ABT) closed at $132.96 in the latest trading session, marking a -0.56% move from the prior day.

Read More
image for news Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
ABT
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Read More
image for news Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds
ABT
Published: May 30, 2025 by: Zacks Investment Research
Sentiment: Positive

ABT sees a 21.6% jump in CGM sales and growing global diagnostics demand, while FX and macro pressure temper its outlook.

Read More
image for news Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds
Abbott (ABT) Rises Higher Than Market: Key Facts
ABT
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Neutral

Abbott (ABT) closed the most recent trading day at $132.85, moving +0.63% from the previous trading session.

Read More
image for news Abbott (ABT) Rises Higher Than Market: Key Facts
Abbott Stock Gains Following FDA Approval of the Tendyne System
ABT
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive

ABT wins FDA approval for its Tendyne TMVR system, offering a minimally invasive mitral valve replacement for high-risk patients with severe MAC.

Read More
image for news Abbott Stock Gains Following FDA Approval of the Tendyne System
4 Dividend Aristocrats Are Absolutely Crushing the S&P 500 in 2025
ABT, CAH, ED, KO
Published: May 23, 2025 by: 24/7 Wall Street
Sentiment: Positive

Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.

Read More
image for news 4 Dividend Aristocrats Are Absolutely Crushing the S&P 500 in 2025
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
ABT
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read More
image for news Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Stifel Has Big Second-Half Stock Market Concerns: 5 Defensive Value Dividend Stocks Buys
ABT, MDLZ, MO, NWN, ZBH
Published: May 20, 2025 by: 24/7 Wall Street
Sentiment: Neutral

If there is one voice on Wall Street that we always listen to, it is Stifel's Barry Bannister, and with good reason.

Read More
image for news Stifel Has Big Second-Half Stock Market Concerns: 5 Defensive Value Dividend Stocks Buys
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
ABT
Published: May 20, 2025 by: Zacks Investment Research
Sentiment: Positive

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Read More
image for news Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs
ABT
Published: May 19, 2025 by: Zacks Investment Research
Sentiment: Positive

Per REFLECT studies, ABT's Libre technology is the first CGM linked to fewer hospitalizations for heart complications in people with diabetes.

Read More
image for news Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs
Abbott (ABT) Up 1.8% Since Last Earnings Report: Can It Continue?
ABT
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Positive

Abbott (ABT) reported earnings 30 days ago. What's next for the stock?

Read More
image for news Abbott (ABT) Up 1.8% Since Last Earnings Report: Can It Continue?
Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes
ABT
Published: May 15, 2025 by: PRNewsWire
Sentiment: Neutral

New data reveal a 78% reduction in cardiovascular disease-related hospitalizations for people living with Type 1 diabetes with prior severe low blood sugar episodes.1 This significant decrease is linked to the use of Libre biowearable technology compared to traditional blood glucose monitors.1 Results also show a reduction in hospitalization for cardiovascular complications in adults with Type 2 diabetes on insulin using Libre technology.2 ABBOTT PARK, Ill., May 15, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced results from its REFLECT real-world studies that show the use of FreeStyle Libre® continuous glucose monitoring (CGM) technology is associated with a significant reduction …

Read More
image for news Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
ABT
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read More
image for news Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races
ABT
Published: May 01, 2025 by: PRNewsWire
Sentiment: Neutral

The test, run on Abbott's portable i-STAT ® Alinity® hand-held instrument, uses whole blood to help evaluate patients 18 years of age and older with a suspected mild traumatic brain injury, or concussion, producing lab-quality results in 15 minutes The test will be used by healthcare professionals in the medical facilities at all MotoAmerica races in 2025 ABBOTT PARK, Ill., and IRVINE, Calif.

Read More
image for news MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races

About Abbott Laboratories (ABT)

  • IPO Date 1980-03-17
  • Website https://www.abbott.com
  • Industry Medical - Devices
  • CEO Robert B. Ford
  • Employees 114000

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.